Balentine LLC’s Madison Square Garden MSGS Stock Holding History

Balentine LLC’s Portfolio MSGS Stock Details MSGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,376	Closed	-$208K	–	672
2022 Q2	$208K	Buy	+1,376	New	+$223K	0.01%	532

Other funds holding MSGS

SLG

Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

SAM

Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $10.2B AUM 30.27% 1-Year Est. Return

Gates Foundation Trust Kirkland, Washington $31.7B AUM 20.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return

Balentine LLC's MSGS Position: Q3 2022 in Review

Balentine LLC sold out of Madison Square Garden (MSGS) in Q3 2022, closing a stake of 1,376 shares — an estimated $208K sold.

Balentine LLC first reported a position in MSGS in Q2 2022 and held it in 1 quarter. The position peaked at $208K in Q2 2022. 258 funds tracked by Wall St. Rank hold MSGS as of Q3 2022.

Balentine LLC reported no remaining Madison Square Garden position as of Q3 2022 after selling out during the quarter.
Balentine LLC sold 1,376 Madison Square Garden shares in Q3 2022, an estimated $208K.
Balentine LLC first reported a position in Madison Square Garden in Q2 2022 and held it in 1 quarter.
Balentine LLC's Madison Square Garden position peaked at $208K in Q2 2022.
258 funds tracked by Wall St. Rank held Madison Square Garden as of Q3 2022.

Based on Balentine LLC's 13F filing for Q3 2022, filed 26 Oct 2022.